https://scholars.lib.ntu.edu.tw/handle/123456789/194498
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 小兒科 | en |
dc.contributor.author | BU, LING-NAN | en |
dc.contributor.author | CHEN, HUEY-LING | en |
dc.contributor.author | CHANG, CHEE-JEN | en |
dc.contributor.author | NI, YEN-HSUAN | en |
dc.contributor.author | HSU, HONG-YUAN | en |
dc.contributor.author | LAI, HONG-SHIEE | en |
dc.contributor.author | HSU, WEN-MING | en |
dc.contributor.author | CHANG, MEI- HWEI | en |
dc.creator | 卜令柟;陳慧玲;張啟仁;倪衍玄;許宏遠;賴鴻緒;許文明;張美惠 | zh_TW |
dc.creator | BU, LING-NAN;CHEN, HUEY-LING;CHANG, CHEE-JEN;NI, YEN-HSUAN;HSU, HONG-YUAN;LAI, HONG-SHIEE;HSU, WEN-MING;CHANG, MEI- HWEI | en |
dc.date | 2003 | en |
dc.date.accessioned | 2008-12-05T04:22:38Z | - |
dc.date.accessioned | 2018-07-11T17:50:20Z | - |
dc.date.available | 2008-12-05T04:22:38Z | - |
dc.date.available | 2018-07-11T17:50:20Z | - |
dc.date.issued | 2003 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/88691 | - |
dc.description.abstract | PURPOSE: The aim of this study was to evaluate the efficacy of trimethoprim-sulfamethoxazole (TMP/SMZ) and neomycin as the prophylactic agents against the recurrence of cholangitis in children with biliary atresia (BA) after a Kasai portoenterostomy. METHODS: Nineteen BA patients aged 0 to 2 years, who had one episode of cholangitis after a Kasai portoenterostomy, were recruited in this study. Patients were assigned randomly into 2 groups: one (9 cases) with TMP/SMZ (TMP 4 mg/kg/d and SMZ 20 mg/kg/d, divided in 2 doses) and the other (10 cases) with neomycin (25 mg/kg/d, qid, 4 days a week). Another 18 BA patients aged 0 to 2 years, with cholangitis but not put on long-term prophylaxis , served as the historical control group. RESULTS: The mean prophylactic periods were 14.6 months and 14.7 months in the TMP/SMZ and neomycin groups. Patients who received prophylaxis with either TMP/SMZ or neomycin had lower recurrence rates of cholangitis than those in the control group (P =.042 and.011). There was no difference in the recurrence rates of cholangitis between the TMP/SMZ and neomycin groups (P =.641). The survival rates were higher in the TMP/SMZ and neomycin groups than in the control group ( P =.09 and.018 ). CONCLUSIONS: Use of TMP/SMZ or neomycin is effective as a prophylactic agent against the recurrence of cholangitis after the Kasai portoenterostomy, but there is no difference in efficacy between these 2 regimens. Copyright 2003, Elsevier Science (USA). All rights reserved. | en |
dc.language | en-us | en |
dc.language.iso | en_US | - |
dc.relation | JOURNAL OF PEDIATRIC SURGERY v.38 n.4 pp.590-593 | en |
dc.relation.ispartof | JOURNAL OF PEDIATRIC SURGERY | - |
dc.title | Prophylactic Oral Antibiotics in Prevention of Recurrent Cholangitis after the Kasai Portoenterostomy | en |
dc.type | journal article | en |
dc.relation.pages | 590-593 | - |
dc.relation.journalvolume | v.38 | - |
dc.relation.journalissue | n.4 | - |
item.languageiso639-1 | en_US | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。